Affiliation:
1. Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
Abstract
BACKGROUND
Recently, two families with hypertrophic cardiomyopathy have been shown to have mutations in the cardiac beta-myosin heavy chain gene (beta-MHC) located on the long arm of chromosome 14.
METHODS AND RESULTS
We have performed linkage analysis of five newly ascertained pedigrees with more than 50 chromosomal markers detecting polymorphisms. Our findings confirm the linkage to beta-MHC gene locus on chromosome 14 in one family (LOD score, 4.50) and suggest linkage to the same gene in another kindred. Chromosome 14 markers were not linked to the disease gene in the other three kindreds, however, and a test for genetic heterogeneity was statistically significant. Moreover, markers for the beta-MHC gene identified affected individuals who were recombinants with respect to this gene and the disease phenotype in these three kindreds.
CONCLUSIONS
These results provide conclusive evidence that hypertrophic cardiomyopathy in separate families is caused by mutations in disease genes at two or more locations in the genome.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference41 articles.
1. Hypertrophie cardiomyopathy: A discussion of nomenclature
2. Hypertrophic Cardiomyopathy
3. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy
4. Barbour DJ Winkler JB Maron BJ Fananapazir L: Signalaveraged electrocardiographic abnormalities in non-affected first degree relatives of patients with hypertrophic cardiomyopathy (abstract). JAm Coll Cardiol 1989;13:190A
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献